• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Matrix metalloproteinase-13 in atherosclerotic plaque is increased by influenza A virus infection

tetano

Editor, Senior Moderator
J Infect Dis. 2019 Nov 6. pii: jiz580. doi: 10.1093/infdis/jiz580. [Epub ahead of print] [h=1]Matrix metalloproteinase-13 in atherosclerotic plaque is increased by influenza A virus infection.[/h]
Lee HS[SUP]1,[/SUP][SUP]2[/SUP], Noh JY[SUP]2[/SUP], Shin OS[SUP]3[/SUP], Song JY[SUP]2[/SUP], Cheong HJ[SUP]2[/SUP], Kim WJ[SUP]1,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h] 1 BK21 Plus Graduate Program Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea (HS.L, WJ.K). 2 Division of Infectious Diseases, Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea (HS.L, JY.N, JY.S, HJ.C, WJ.K). 3 Department of Biomedical Sciences, Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea (OS. S).

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza virus infection triggers acute cardiovascular events. Several studies have demonstrated that influenza A virus infection was associated with immune cell influx and increased production of inflammatory cytokines in the atherosclerotic plaque lesion, but the underlying mechanism for these findings is not clear.
[h=4]METHODS:[/h] We examined the expression levels of matrix metalloproteinases by influenza A virus infection in human cells using quantitative RT-PCR, Western blot and human MMP-13 ELISA assay. In an animal study, protein expression in the plaque lesions of ApoE-deficient mice were analyzed by immunohistochemistry and Western blot.
[h=4]RESULTS:[/h] We confirmed that matrix metalloproteinase-13 was increased in influenza A virus-infected cells. In the aorta of infected ApoE-deficient mice, matrix metalloproteinase-13 was increased at 3 days after infection. Immunohistochemical staining results suggested that collagen was degraded in the matrix metalloproteinase-13 expression area and that macrophages were the main source of matrix metalloproteinase-13 expression. Furthermore, the expression of matrix metalloproteinase-13 was regulated by influenza A virus through activation of the p38 MAPK signal pathway.
[h=4]CONCLUSIONS:[/h] In this study, we demonstrated that p38 MAPK-mediated matrix metalloproteinase-13 expression by influenza A virus infection led to destabilization of vulnerable atherosclerotic plaques in artery. (191 words).
? The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.


[h=4]KEYWORDS:[/h] Atherosclerosis; Influenza A virus; Matrix Metalloproteinase-13; p38 Mitogen-Activated Protein Kinase

PMID: 31693113 DOI: 10.1093/infdis/jiz580
 
Back
Top Bottom